VTAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Catheter Precision Inc (VTAK) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, financial performance shows significant losses, and there are no strong positive catalysts or trading signals to support immediate investment. It is better to monitor the stock for future developments.
The MACD is slightly positive but contracting, indicating weakening momentum. The RSI is neutral at 40.951, showing no clear trend. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the price is below the pivot level of 1.026, with key support at 0.843 and resistance at 1.209.
NULL identified. The stock has a 40% chance to gain modestly (3.82%) in the next day, but this is not a strong or reliable catalyst for long-term investment.
Bearish moving averages, declining financial performance (net income and EPS significantly down YoY), and no significant insider or hedge fund activity. Pre-market price is down 1.42%, indicating weak sentiment.
In 2025/Q4, revenue increased by 59.73% YoY to $238,000, but net income dropped by 46.43% YoY to -$5,778,000. EPS declined significantly by 84.21% YoY to -3.41, and gross margin slightly decreased to 91.6%. Overall, the company is struggling with profitability despite revenue growth.
No analyst rating or price target changes available for this stock.
